Dong Ji

11PUBLICATIONS
23CO-AUTHORS
ChemotherapyWater treatment processesLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 03, 2026
HBsAg Quantification-Based Models for Predicting Hepatocellular Carcinoma Risk in Nucleos(t)ide Analogs-Experienced Patients With Chronic Hepatitis B: The HBsAg-HCC Score.

Yi-Fan Guo, Xiao-Xia Niu, Le Li

|Mar 11, 2026
Repurposing SGLT2 Inhibitors for Cirrhotic Ascites: From Mechanistic Research to Clinical Exploration.

Yuan Gao, Yunyi Gao, Dong Ji

|Feb 04, 2025
Efficacy and safety of switching from entecavir to tenofovir alafenamide in chronic hepatitis B patients with low-level viremia: a real-world 48-week extension study.

Meng-Wen He, Li Cui, Dan-Dan Chen

|Mar 14, 2024
An optimized short-term steroid therapy for chronic drug-induced liver injury: A prospective randomized clinical trial.

Ang Huang, Yun Zhu, Shuhong Liu

|May 19, 2023
Clinical characteristics and prognosis of non-APAP drug-induced acute liver failure: a large multicenter cohort study.

Lin Han, Ang Huang, Jinjun Chen

|Jul 25, 2022
Characteristics of HBV Novel Serum Markers across Distinct Phases in Treatment-Naïve Chronic HBV-Infected Patients.

Hao Liao, Le Li, Wei V Zheng

Pageof 2

Frequent Collaborators

4 joint publications

Zhengsheng Zou

2 joint publications

Jia-Bo Wang

2 joint publications

Yijin Wang

2 joint publications

Jingmin Zhao